Dialysis-related amyloidosis.

نویسندگان

  • T Bardin
  • J Zingraff
  • D Kuntz
  • T Drüeke
چکیده

end-stage failure patients which has been recognized a Amyloid arthropathy decade ago. It generally occurs after several years of The deposition of b2M amyloid clearly is associated renal replacement therapy [1,2]. However, it may be with the syndrome of chronic arthralgias and arthropaseen occasionally in patients with long-standing, severe thy in dialysis patients, although the precise pathogenrenal failure who are not yet treated by dialysis or etic role played by amyloid deposits still needs to be related procedures [3,4]. It is mainly localized in osteoclarified. Its incidence augments with increasing time articular structures. It is often associated with the on dialysis and with ageing [10]. The condition has occurrence of the carpal tunnel syndrome and painful, been described mainly in patients dialysed with the chronic arthropathies that may evolve to progressive cuprophane membrane but the use of synthetic, highly joint destruction. permeable dialysis membrane offers no absolute longIn 1985, two groups of workers showed that term protection. It would appear that once the amylb2-microglobulin (b2M) was the major constituent oidogenetic process has started it is difficult, if not protein of dialysis-associated amyloidosis [5,6 ], even impossible, to stop it completely, even by changing the though a number of other proteins have been found dialysis procedure. since in the amyloid deposits as well, including serumThe chronic arthralgias are usually bilateral and derived amyloid P component (SAP), glycosaminooften involve the shoulders initially. Other joints, in glycans, proteases, antiproteases, ubiquitin, and particular the knees, wrists and small joints of the immunoglobulin light chains [7,8]. The b2M protein hands, may be involved as well. Chronic joint swelling accumulates in the plasma of chronically uraemic is another important feature of the disease, as may be patients, and this accumulation is almost certainly a recurrent hemarthrosis and chronic tenosynovitides of major contributing factor in the formation and tissue the finger flexors. deposition of b2M amyloid and associated pathological Destructive arthropathies of large peripheral joints conditions. However, several other factors appear to and of the spine may ensue, causing major incapacity. play an important role as well which are discussed Massive amyloid deposits are almost constantly below. observed at the site of such lesions [11,12]. They are

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Influence of heparin molecular size on the induction of C-terminal unfolding in β2-microglobulin

Dialysis-related amyloidosis (DRA) is characterized by accumulation of amyloid β2-microglobulin (β2m) in the interstitial matrix. Matrix substances such as heparin have reportedly been strongly implicated in the pathogenesis of dialysis-related amyloidosis. In clinical setting of hemodialysis, two types of heparin, i.e., high and low molecular heparin (H.M.H. and L.M.H.) have been routinely use...

متن کامل

Dialysis-Related Amyloidosis: Pathogenesis and Clinical Features in Patients Undergoing Dialysis Treatment

To date, there are 27 types of amyloidosis known extracellular fibril proteins in human, and each amyloidosis is characterized amyloid protein precursor, systemic (S) or localized organ (L), and syndrome or involved tissues [1]. In the nomenclature, dialysis-related amyloidosis (DRA) is defined as β2-microglobulin-related (Aβ2M) amyloid which precursor protein is β2microglobulin (β2-m). It is a...

متن کامل

A case of pulmonary dialysis-related amyloidosis with reticular opacity of the lung in a patient undergoing long-term dialysis

Dialysis-related amyloidosis (DRA) is one of the most important complications in long-term dialysis patients. Pulmonary involvement in patients with DRA has been rarely described, and lung radiographic findings have not yet been reported. The most common chronic lung disease process in chronic dialysis patients is interstitial fibrosis. This is the first case report of DRA presenting in the lun...

متن کامل

Dialysis amyloidosis: clinical aspects and therapeutic approach.

Long-term survival of patients with chronic renal failure treated with regular haemodialysis has recently been recognized to be associated with peculiar complications which involve the osteoarticular system [1]. Such complications are related to a new form of systemic amyloidosis which is due to /?2-microglobulin (/J2-M), a protein which is catabolized by normal kidneys and accumulates when ren...

متن کامل

Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years.

BACKGROUND Dialysis-related amyloidosis is one of the chronic the complications of haemodialysis. We conducted an investigation of dialysis-associated amyloidosis in extremely long-term survivors. METHODS Twenty-one patients on haemodialysis for more than 30 years ('30+' group) and 13 patients on haemodialysis for 20-30 years ('20-30' group) at Sangenjaya Hospital were enrolled in this study....

متن کامل

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.

BACKGROUND There are few reports regarding the long-term renal replacement therapy (RRT) outcomes of amyloidosis. METHODS In this retrospective, multi-centre, multi-country registry analysis, all patients with and without amyloidosis who commenced RRT for end-stage renal failure (ESRF) in Australia and New Zealand between 1963 and 2010 were included. RESULTS Of 58 422 patients who underwent...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of rheumatology

دوره 14 4  شماره 

صفحات  -

تاریخ انتشار 1986